Chronic Plaque Psoriasis — MRCGP AKT MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Change corticosteroid formulation and address adherent scale
The best answer is “Change corticosteroid formulation and address adherent scale”. NICE advises checking adherence and application, then considering a different potent corticosteroid formulation or a scale-softening preparation before further treatment. A vitamin-D analogue or combination product may follow if response remains inadequate. Systemic treatment needs specialist assessment.
Reference: NICE CG153: Psoriasis assessment and management: https://www.nice.org.uk/guidance/cg153/chapter/Recommendations